Latest Breaking News On - சுவிஸ் ஸ்டாக் - Page 6 : comparemela.com

International PolyPeptide Group Chooses SIX For Its IPO Date 29/04/2021 Today, PolyPeptide Group AG (Ticker PPGN ), a global leader in peptide development and manufacturing, listed its shares on the Swiss Stock Exchange. The opening price was CHF 72.50 per share, resulting in a market capitalization of CHF 2.4 billion. With PolyPeptide Group, SIX welcomes another company from the life sciences sector, further expanding its strong peer group and strengthening its position as Europe’s leading exchange for life sciences companies. The issued share capital of PolyPeptide comprises of 33,125,001 registered shares, whereas 3,125,000 newly issued registered shares together with existing 8,396,740 registered shares were offered in the IPO. At an issue price of CHF 64.00 per registered share, the placement volume was CHF 737 million (excluding over-allotment option). In addition, the selling shareholder has granted an overallotment option of up to 1,728,261 existing shares.

Jos dijsselhofPeter wildenSwiss stock exchangePolypeptide groupPolypeptide group ag tickerSwiss stockChairman polypeptideசுவிஸ் ஸ்டாக் பரிமாற்றம்சுவிஸ் ஸ்டாக்